<
 
 
 
 
×
>
hide
You are viewing a Web site, archived on 07:16:12 Oct 16, 2004. It is now a Federal record managed by the National Archives and Records Administration.
External links, forms, and search boxes may not function within this collection.
Dockets Open for Comment

If your comments are NOT related to a docket listed below, you can submit written comments to Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, MD 20852.

Docket SearchDocket Summary Report
Frequently Asked Questions
Dockets Open for Comment 111 Dockets

    
Docket
ID
Title Published
Date
Comment
Period Ends
Submit
Comment
2004N-0033 Establishing a Docket regarding the Factor VIII Inhibitor Workshop of November 21, 2003 07/02/04 06/06/06 Go
2003D-0117 Guidance for Industry, FDA Staff, and Third Parties; Implementation of the Inspection by Accredited Persons Program Under the Medical Device User Fee and Modernization Act of 2002; Accreditation Criteria; Availability 10/04/04 10/04/05 Go
2003D-0380 Guidance for Industry, PAT - A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance 10/04/04 10/04/05 Go
2004D-0414 Guidance for Industry: FDA Review of Vaccine Labeling Requirements for Warnings, Use Instructions, and Precautionary Information 10/04/04 10/04/05 Go
2003D-0382 Final Guidance for Industry on 10/04/04 10/04/05 Go
2004D-0438 Guidance for Industry: Use of Material from Bovine Spongiform Encephalopathy-Positive Cattle in Animal Feed; Availability 09/29/04 09/29/05 Go
2004D-0412 Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Sirolimus Test Systems; Availability 09/29/04 09/29/05 Go
2004D-0371 Immunology and Microbiology Devices; Classification of the Beta-Glucan Serological Assay; Guidance Document; Availability 09/23/04 09/23/05 Go
2004N-0404 Notice of Public Meeting - Novel Formulations of Dialysis Solutions 09/10/04 09/15/05 Go
2002D-0320 Guidance for Industry and Clinical Investigators on the Use of Clinical Holds Following Clinical Investigator Misconduct; Availability 09/01/04 09/01/05 Go
2003D-0391 Draft guidances for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Dental Noble Metal Alloys and Class II Special Controls Guidance Document: Dental Base Metal Alloys; Availability 08/20/04 08/22/05 Go
2003D-0112 Guidance for Industry on Independent Consultants for Biotechnology Clinical Trial Protocols; Availability 08/19/04 08/19/05 Go
2003D-0554 Compliance Policy Guide Sec. 110.310 - 08/12/04 08/16/05 Go
2004D-0361 Guidance for Industry; Prior Notice of Imported Food Contingency Plan for Systems Outages; Availability 08/16/04 08/16/05 Go
2004N-0330 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee 07/30/04 07/29/05 Go

  1 to 15

 

[www.fda.gov]